Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Roblin

Showing results (161-170 of 252) with videos related to

Pageof 26
Sort By:
Alimentary Pharmacology & Therapeutics|March 1, 2022
Subcutaneous injection of infliximab CT-P13 results in stable drug levels within 14-day treatment cycle in Crohn's diseaseXavier Roblin, Pauline Veyrard, Laetitia Bastide, et al.
Inflammatory Bowel Diseases|March 6, 2018
IBD-INFO Questionnaire: A Multicenter French Up-to-Date Survey of Patient Knowledge in Inflammatory Bowel DiseasePauline Danion, Anthony Buisson, Xavier Roblin, et al.
Plos Biology|September 27, 2013
Dectin-1 is essential for reverse transcytosis of glycosylated SIgA-antigen complexes by intestinal M cellsNicolas Rochereau, Daniel Drocourt, Eric Perouzel, et al.
Therapeutic Drug Monitoring|March 1, 2019
Comparison of Immunoassays for Measuring Serum Levels of Golimumab and Antibodies Against Golimumab in Ulcerative Colitis: A Retrospective Observational StudyAnne-Emmanuelle Berger, Gerard Duru, Annick de Vries, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 12, 2016
Laparoscopy could be the best approach to treat colorectal cancer in selected patients aged over 80 years: Outcomes from a multicenter studyLeslie Rinaldi, Mehdi Ouaissi, Gabriele Barabino, et al.
Inflammatory Bowel Diseases|May 3, 2018
Is the Pharmacokinetic Profile of a First Anti-TNF Predictive of the Clinical Outcome and Pharmacokinetics of a Second Anti-TNF?Xavier Roblin, Céline Vérot, Stéphane Paul, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 31, 2019
Oral Curcumin No More Effective Than Placebo in Preventing Recurrence of Crohn's Disease After Surgery in a Randomized Controlled TrialGilles Bommelaer, David Laharie, Stéphane Nancey, et al.
Inflammatory Bowel Diseases|May 2, 2015
Infliximab Does Not Worsen Outcomes During Flare-ups Associated with Cytomegalovirus Infection in Patients with Ulcerative ColitisSylvie Pillet, Camille Jarlot, Mathilde Courault, et al.
Inflammatory Bowel Diseases|May 23, 2018
6-Thioguanine Nucleotide Levels Are Associated With Mucosal Healing in Patients With Crohn's DiseaseRen Mao, Jing Guo, Raphael Luber, et al.
Inflammatory Bowel Diseases|August 18, 2021
Swapping Versus Dose Optimization in Patients Losing Response to Adalimumab With Adequate Drug LevelsXavier Roblin, Capucine Genin, Stéphane Nancey, et al.
Pageof 26

Showing results (161-170 of 252) with videos related to

Sort By:
Pageof 26
Alimentary Pharmacology & Therapeutics|March 1, 2022
Subcutaneous injection of infliximab CT-P13 results in stable drug levels within 14-day treatment cycle in Crohn's diseaseXavier Roblin, Pauline Veyrard, Laetitia Bastide, et al.
Inflammatory Bowel Diseases|March 6, 2018
IBD-INFO Questionnaire: A Multicenter French Up-to-Date Survey of Patient Knowledge in Inflammatory Bowel DiseasePauline Danion, Anthony Buisson, Xavier Roblin, et al.
Plos Biology|September 27, 2013
Dectin-1 is essential for reverse transcytosis of glycosylated SIgA-antigen complexes by intestinal M cellsNicolas Rochereau, Daniel Drocourt, Eric Perouzel, et al.
Therapeutic Drug Monitoring|March 1, 2019
Comparison of Immunoassays for Measuring Serum Levels of Golimumab and Antibodies Against Golimumab in Ulcerative Colitis: A Retrospective Observational StudyAnne-Emmanuelle Berger, Gerard Duru, Annick de Vries, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 12, 2016
Laparoscopy could be the best approach to treat colorectal cancer in selected patients aged over 80 years: Outcomes from a multicenter studyLeslie Rinaldi, Mehdi Ouaissi, Gabriele Barabino, et al.
Inflammatory Bowel Diseases|May 3, 2018
Is the Pharmacokinetic Profile of a First Anti-TNF Predictive of the Clinical Outcome and Pharmacokinetics of a Second Anti-TNF?Xavier Roblin, Céline Vérot, Stéphane Paul, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 31, 2019
Oral Curcumin No More Effective Than Placebo in Preventing Recurrence of Crohn's Disease After Surgery in a Randomized Controlled TrialGilles Bommelaer, David Laharie, Stéphane Nancey, et al.
Inflammatory Bowel Diseases|May 2, 2015
Infliximab Does Not Worsen Outcomes During Flare-ups Associated with Cytomegalovirus Infection in Patients with Ulcerative ColitisSylvie Pillet, Camille Jarlot, Mathilde Courault, et al.
Inflammatory Bowel Diseases|May 23, 2018
6-Thioguanine Nucleotide Levels Are Associated With Mucosal Healing in Patients With Crohn's DiseaseRen Mao, Jing Guo, Raphael Luber, et al.
Inflammatory Bowel Diseases|August 18, 2021
Swapping Versus Dose Optimization in Patients Losing Response to Adalimumab With Adequate Drug LevelsXavier Roblin, Capucine Genin, Stéphane Nancey, et al.
Pageof 26